Category: Johnny Zhou, PharmD Portfolio

PharmD graduate looking to incorporate scientific/clinical knowledge into medical communication. I am experienced in community, retail, and industry cross-functional settings through my four years of education in pharmacy. My two years of experience in research have equipped me with a solid ability to conduct thorough literature reviews and capabilities to translate information into patient-friendly language. Passionate to explore new opportunities combining therapeutic knowledge and strategic planning to provide meaningful change for patients.

My interest in medical writing stems from the industry’s potential to help patients’ lives through innovative medical communication. What attracts me to work with different businesses is their commitment to translating complex data into impactful medical communication. I believe that effectively communicating scientific knowledge from the patient perspective and forging it with the desire to improve their lives allows for innovation.

My experience in pharmacy and research has been enriching and informative regarding changes to health care and providing content to the public. I am eager to take on a role in analyzing scientific information and representing them in medical communication initiatives. I confidently believe that medical communication is a discipline that will allow me to view problems from the patient’s standpoint and the marketplace’s point of view.

The therapeutic areas I have expertise/interest in are gastrointestinal conditions, transplants, and pain management. Related fields I am passionate about include pharmacoeconomics, pharmacokinetics, and data analytics. Outside of work, I enjoy snowboarding, swimming, and biking. A trip to the Rockies is always a good time for me!

I look forward to the opportunity to hear from your team!

Posted on

Should I get a Humira Biosimilar?

Dunleavy K. Next Year, When AbbVie Loses Its Exclusivity for Humira in the U.S., Nearly a Dozen Companies Will Be Ready with Biosimilars to Claim a Piece of a Lucrative Market. Of Humira’s $20.6 Million Sales in 2021, $17.3 Billion Came in the U.S. (AbbVie). Fierce Pharma; 2022. https://www.fiercepharma.com/manufacturing/abbvie-says-supply-capabilities-will-be-key-differentiator-between-humiras-biosimilar. Accessed March 9, 2023. At some …

Continue reading "Should I get a Humira Biosimilar?"

Posted on

Low FODMAP diet in Ulcerative Colitis: fad or fact?

Waldbieser J. Fodmap diets for ulcerative colitis. EverydayHealth.com. https://www.everydayhealth.com/ulcerative-colitis/ulcerative-colitis-low-fodmap-diet/. Accessed January 26, 2023. For most people who have seen a medical professional, diet and exercise are one of the most recommended non-drug options. With so many different diets seen on social media sites, it can be confusing to decide what options work well for you. …

Continue reading "Low FODMAP diet in Ulcerative Colitis: fad or fact?"